ES8601875A1 - Un procedimiento para preparar de rivados de azetidinona - Google Patents

Un procedimiento para preparar de rivados de azetidinona

Info

Publication number
ES8601875A1
ES8601875A1 ES539161A ES539161A ES8601875A1 ES 8601875 A1 ES8601875 A1 ES 8601875A1 ES 539161 A ES539161 A ES 539161A ES 539161 A ES539161 A ES 539161A ES 8601875 A1 ES8601875 A1 ES 8601875A1
Authority
ES
Spain
Prior art keywords
groups
carbon atoms
different
group
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539161A
Other languages
English (en)
Other versions
ES539161A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Hoechst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst UK Ltd filed Critical Hoechst UK Ltd
Publication of ES8601875A1 publication Critical patent/ES8601875A1/es
Publication of ES539161A0 publication Critical patent/ES539161A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE AZETIDINONA. CONSISTE EN SOMETER A UNA REACCION DE HALOGENACION A UN COMPUESTO DE FORMULA (II) PARA OBTENER UN COMPUESTO DE FORMULA (I); LA PROPORCION (I):(II), DEPENDE DEL AGENTE HALOGENANTE UTILIZADO Y DE LAS CONDICIONES DE REACCION, VARIA ENTRE 3:1 A 9:1. SIENDO: R, H O UN GRUPO ESTERIFICADOR DE CARBOXILO; R1 UN GRUPO FENILO, NAFTILO, TIENILO Y OTROS; R8 UN GRUPO ALCOHILO CON C 1 A 8, UN GRUPO ALQUENILO CON C 1 A 4 Y OTROS; R9 UN GRUPO ALCOHILO CON C 1 A 4 O UN GRUPO FENILO; Y R10 UN ATOMO DE CLORO O BROMO. SE UTILIZAN EN LA PREPARACION DE SUSTANCIAS QUE TIENEN ACTIVIDAD ANTIBACTERIANA Y ACTIVIDAD INHIBIDORA Y/O INACTIVADORA DE B-LACTAMASA.
ES539161A 1982-07-08 1984-12-28 Un procedimiento para preparar de rivados de azetidinona Granted ES539161A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8219745 1982-07-08

Publications (2)

Publication Number Publication Date
ES8601875A1 true ES8601875A1 (es) 1985-11-01
ES539161A0 ES539161A0 (es) 1985-11-01

Family

ID=10531540

Family Applications (3)

Application Number Title Priority Date Filing Date
ES523890A Granted ES523890A0 (es) 1982-07-08 1983-07-06 Un procedimiento para preparar derivados de penem.
ES539161A Granted ES539161A0 (es) 1982-07-08 1984-12-28 Un procedimiento para preparar de rivados de azetidinona
ES539160A Expired ES8602013A1 (es) 1982-07-08 1984-12-28 Un procedimiento para preparar derivados de penem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES523890A Granted ES523890A0 (es) 1982-07-08 1983-07-06 Un procedimiento para preparar derivados de penem.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES539160A Expired ES8602013A1 (es) 1982-07-08 1984-12-28 Un procedimiento para preparar derivados de penem

Country Status (22)

Country Link
US (1) US4738959A (es)
EP (1) EP0099059B1 (es)
JP (1) JPS5921693A (es)
KR (1) KR900007181B1 (es)
AT (1) ATE35270T1 (es)
AU (1) AU567103B2 (es)
CA (1) CA1227194A (es)
DE (1) DE3377132D1 (es)
DK (1) DK314483A (es)
ES (3) ES523890A0 (es)
FI (1) FI77662C (es)
GB (2) GB2122619B (es)
GR (1) GR78890B (es)
HU (3) HU193459B (es)
IE (1) IE55581B1 (es)
IL (1) IL69174A0 (es)
MA (1) MA19842A1 (es)
NO (3) NO832487L (es)
NZ (1) NZ204829A (es)
PH (1) PH23148A (es)
PT (1) PT76996B (es)
ZA (1) ZA834955B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE28648T1 (de) * 1982-03-26 1987-08-15 Hoechst Uk Ltd 7-oxo-4-thia-1-azabicyclo(3,2,0)heptan-derivate
GB2197864B (en) * 1984-06-29 1989-05-17 Hoechst Uk Ltd Antibacterial 7-oxo-4-thia-1-azabicyclo(3.2.0)-hept-2-ene derivatives
GB2197865B (en) * 1984-06-29 1989-05-17 Hoechst Uk Ltd Azetidinone derivatives
GB8416565D0 (en) * 1984-06-29 1984-08-01 Hoechst Uk Ltd Antibacterial derivatives
GB2164334B (en) * 1984-09-10 1988-08-03 Hoechst Uk Ltd Antibacterial 7-oxo-4-thia-1-azabicyclo 3,2,0 hept-2-ene derivativess
JPS61236785A (ja) * 1985-04-15 1986-10-22 Sankyo Co Ltd アゼチジノン誘導体
US4797394A (en) * 1985-10-29 1989-01-10 Pfizer Inc. 6-(1-carbamoyl-1-hydroxymethyl)penicillanic acid derivatives
US4868296A (en) * 1985-10-29 1989-09-19 Pfizer Inc. 6-(1-carbamoyl-1-hydroxymethyl) penicillanic acid derivatives
JPS62179860A (ja) * 1986-01-31 1987-08-07 Sintokogio Ltd 低圧鋳造装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301074A (en) * 1977-11-17 1981-11-17 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-substituted-pen-2-em-3-carboxylic acid
US4168314A (en) * 1977-11-17 1979-09-18 Merck & Co., Inc. 6-(1'-Hydroxyethyl)-2-aminoethylthio-pen-2-em-3-carboxylic acid
EP0003960B1 (de) * 1978-02-02 1983-06-29 Ciba-Geigy Ag 6-Substituierte Thia-Azaverbindungen, ihre Herstellung und diese enthaltende pharmazeutische Präparate
JPS5625110A (en) * 1978-12-18 1981-03-10 Bristol Myers Co Antibacterial
JPS56115788A (en) * 1980-02-19 1981-09-11 Sankyo Co Ltd Azetidinone derivative and its preparation
US4395418A (en) * 1980-06-06 1983-07-26 Sankyo Company Limited Penem-3-carboxylic acid derivatives
GB2083462B (en) * 1980-08-16 1984-05-02 Beecham Group Ltd 2-thiopenem derivatives
US4347183A (en) * 1981-02-02 1982-08-31 Schering Corporation Process for the synthesis of penems and carbapenems
US4431658A (en) * 1981-02-02 1984-02-14 Schering Corporation Aza penem compounds
ES8305366A1 (es) * 1981-07-08 1983-04-01 Hoechst Uk Ltd "procedimiento para la preparacion de derivados de penem".
DE3274982D1 (en) * 1981-07-08 1987-02-12 Hoechst Uk Ltd Antibacterial penem derivatives

Also Published As

Publication number Publication date
KR900007181B1 (ko) 1990-09-29
DE3377132D1 (en) 1988-07-28
EP0099059A1 (en) 1984-01-25
KR840005453A (ko) 1984-11-12
ES539160A0 (es) 1985-11-01
PT76996B (en) 1986-03-12
HU193459B (en) 1987-10-28
IE831592L (en) 1984-01-08
NZ204829A (en) 1986-07-11
IE55581B1 (en) 1990-11-07
ES8602013A1 (es) 1985-11-01
AU1665383A (en) 1984-01-12
GB2160865B (en) 1986-11-26
GB2122619B (en) 1986-01-08
ZA834955B (en) 1984-03-28
GB8318513D0 (en) 1983-08-10
FI77662C (fi) 1989-04-10
DK314483A (da) 1984-01-09
NO842960L (no) 1984-01-09
JPS5921693A (ja) 1984-02-03
IL69174A0 (en) 1983-11-30
FI832479L (fi) 1984-01-09
GB2122619A (en) 1984-01-18
PT76996A (en) 1983-08-01
FI77662B (fi) 1988-12-30
AU567103B2 (en) 1987-11-12
GB8515248D0 (en) 1985-07-17
ES8504203A1 (es) 1985-04-01
MA19842A1 (fr) 1984-04-01
CA1227194A (en) 1987-09-22
NO841108L (no) 1984-01-09
FI832479A0 (fi) 1983-07-06
GB2160865A (en) 1986-01-02
HUT40622A (en) 1987-01-28
GR78890B (es) 1984-10-02
US4738959A (en) 1988-04-19
ATE35270T1 (de) 1988-07-15
HU193460B (en) 1987-10-28
DK314483D0 (da) 1983-07-07
EP0099059B1 (en) 1988-06-22
ES539161A0 (es) 1985-11-01
ES523890A0 (es) 1985-04-01
PH23148A (en) 1989-05-11
NO832487L (no) 1984-01-09
HU192819B (en) 1987-07-28

Similar Documents

Publication Publication Date Title
FI862621A (fi) Estrar av (met)-akrylsyror och deras anvaendning.
ES8601875A1 (es) Un procedimiento para preparar de rivados de azetidinona
FI853717A0 (fi) 3-amino-2-benzoyl -akrylsyraderivat och foerfarande foer deras framstaellning.
SE8302694D0 (sv) Immunomodulating agent
FR2431505A1 (fr) Nouveaux n-(diaminophosphinyl)arylcarboxamides, utiles notamment comme inhibiteurs de l'urease
ES2052935T3 (es) Composicion topica.
DE3785803D1 (de) 4-cyano(nitro)-5-oxy(thio)-pyrazol-derivate.
EP0202654A3 (en) 5-carboxy-1,4-dihydropyrimidine derivatives
EP0214732A3 (en) (substituted benzyl)-thio heterocyclic compounds having a leukotriene-antagonist activity
PT89263A (pt) Processo para a preparacao de derivados tiol-cetona ou tiol-aldeido
ATE37183T1 (de) Chinazolin- und isochinolin-derivate.
GB1467217A (en) Cephalosporin-type antibiotics and process for producing the same
ES463234A1 (es) Procedimiento para preparar compuestos de aril azufre.
FR2220257A1 (en) 5,6-Dihydro-(4H)-s-triazolo-(4,3-a) (1,5)benzodiazepines - as antiinflam-matory and analgesic agents without tranquillising effects
DE3768479D1 (de) 2,3-diaminoacrylonitrilderivate.
ES8307209A1 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
ID22444A (id) Bis (akridinkarboksamida) dan bis (fenozinkarboksamida) sebagai zat anti tumor
ES8100238A1 (es) Un procedimiento para la preparacion de derivados del acido oxisustituido-ciclohexilacetico
ES8601225A1 (es) Procedimiento para preparar derivados de triazol e imidazol
FR2428647A1 (fr) Iminothiazolyl ureido cephalosporines a action antibacterienne
JPS52106883A (en) Novel penicillins and cephalosporins
ES8500223A1 (es) Un metodo de preparacion de derivados de oximas de halogenobenzofenonas.
GB1044853A (en) Improvements in or relating to novel ether derivatives of benzmorphans
ES448967A1 (es) Procedimiento para producir nuevos esteres malonicos.
IT1204495B (it) Procedimento di sintesi per l'ottenimento di molecole aventi attivita' farmacologica via uree mono e bisostiuite